Goldman Sachs cuts Nanobiotix stake to 3.78%

• Goldman Sachs cut its stake in Nanobiotix below 5% on Aug. 24.
• Holding fell to 1,921,176 shares, equal to 3.78% of share capital, 3.52% of voting rights.
• Move followed an off-market sale of shares.
• Position includes 1,478,840 shares via 17 cash-settled swap contracts, exercisable through Aug. 20, 2036.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nanobiotix SA published the original content used to generate this news brief on September 21, 2026, and is solely responsible for the information contained therein.